The SPDR S&P Biotech ETF (XBI) saw an estimated $591.0M inflow, up 5.8% week-over-week, indicating improving near-term demand for biotech exposure. While not a fundamentals update, the flow trend is supportive of risk sentiment toward the group.
The SPDR S&P Biotech ETF (XBI) saw an estimated $591.0M inflow, up 5.8% week-over-week, indicating improving near-term demand for biotech exposure. While not a fundamentals update, the flow trend is supportive of risk sentiment toward the group.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
